PFIZER BREAKTHROUGH GROWTH INITIATIVE
The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with small- to medium-sized market capitalizations across a range of therapeutic categories that are consistent with Pfizer’s core areas of focus: Internal Medicine, Inflammation & Immunology, Oncology, Rare Disease, Vaccines and Hospital.
PFIZER BREAKTHROUGH GROWTH INITIATIVE
Founded:
2020-06-01
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | AgomAb Therapeutics | Pfizer Breakthrough Growth Initiative investment in Series B - AgomAb Therapeutics | 38.4 M EUR |
| 2022-06-16 | Akero Therapeutics | Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Akero Therapeutics | 25 M USD |
| 2021-11-18 | Cardiff Oncology | Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Cardiff Oncology | 15 M USD |
| 2021-01-12 | ESSA Pharma | Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - ESSA Pharma | 10 M USD |
| 2021-01-12 | Vedanta Biosciences | Pfizer Breakthrough Growth Initiative investment in Venture Round - Vedanta Biosciences | 25 M USD |
| 2020-11-09 | Homology Medicines | Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Homology Medicines | 60 M USD |
| 2020-09-08 | Trillium Therapeutics | Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Trillium Therapeutics | 25 M USD |
More informations about "Pfizer Breakthrough Growth Initiative"
Pfizer Invests $120 Million in Biotechnology Innovation Through …
Jan 12, 2021 Established in June 2020, the Pfizer Breakthrough Growth Initiative focuses on non-controlling equity investments primarily in public companies with small- to medium-sized …See details»
Pfizer Establishes New Program to Support Continued …
Jun 2, 2020 Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. …See details»
Pfizer Breakthrough Growth Initiative - Crunchbase
The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with small- to medium …See details»
Pfizer Invests in Biotechnology Innovation through the Pfizer ...
Through the newly-created Pfizer Breakthrough Growth Initiative (PBGI), Pfizer is investing in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help …See details»
Pfizer Invests $120 Million in Biotechnology Innovation Through …
Established in June 2020, the Pfizer Breakthrough Growth Initiative focuses on non-controlling equity investments primarily in public companies with small- to medium-sized market …See details»
Pfizer Invests $120 Million in Biotechnology Innovation …
Jan 12, 2021 Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative First four investments of new program created to support clinical-stage biotechnology ...See details»
View PDF - Pfizer
Established in June 2020, the Pfizer Breakthrough Growth Initiative focuses on non-controlling equity investments primarily in public companies with small- to medium-sized market …See details»
Pfizer Establishes New Program to Support Continued …
The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with small- to medium …See details»
Pfizer Establishes New Program to Support Continued …
Jun 2, 2020 The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with …See details»
Pfizer Establishes New Program to Support Continued ... - Nasdaq
Jun 2, 2020 The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with …See details»
Pfizer business head details new $500M project for investing in …
Jun 3, 2020 Pfizer announced Tuesday that it had launched a new initiative for investing in biotechnology companies and committed up to $500 million to fund the effort. The Pfizer …See details»
View PDF - Pfizer
The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with small- to medium …See details»
Pfizer Inc. - Pfizer Establishes New Program to Support Continued ...
Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies Pfizer Inc. (NYSE: PFE) today announced the establishment …See details»
Pfizer Invests $120M to Advance Biotechnology Innovation
Jan 14, 2021 Through the Pfizer Breakthrough Growth Initiative (PBGI), the company’s initial allocations include $10 million to Canada-based ESSA Pharma, a clinical-stage …See details»
Pfizer Establishes New Program to Support Continued …
Jun 2, 2020 The Pfizer Breakthrough Growth Initiative will focus on making non-controlling equity investments in clinical-stage public companies, with a primary focus on companies with …See details»
Pfizer Breakthrough Growth Initiative - Investments, Portfolio ...
Pfizer Breakthrough Growth Initiative has made 9 investments. Their most recent investment was on Jan 30, 2024, when Cour Pharmaceuticals Development raisedSee details»
Pfizer Growth Initiative Invests $120 Million into Four Companies
Jan 13, 2021 The Pfizer Breakthrough Growth Initiative has invested a total of $120 million into four separate clinical-stage biotech companies. Pfizer anticipates the initiative to invest up to …See details»
Pfizer establishes new program to support continued …
Jun 9, 2020 Pfizer Inc. today announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help …See details»
Pfizer Breakthrough Growth Initiative will invest up to $500 million …
Jun 3, 2020 Pfizer (NYSE: PFE), at a time when the COVID-19 pandemic is disrupting drugmakers clinical trials activities, on Tuesday announced the establishment of the Pfizer …See details»
Pfizer Breakthrough Growth Initiative - life-sciences-usa.com
Pfizer Breakthrough Growth Initiative, which provides funding and access to Pfizer’s scientific expertise to support biotechnology companies’ most promising clinical development programs.See details»